Sun Pharmaceuticals Industries Ltd

NSE :SUNPHARMA   BSE :524715  Sector : Pharmaceuticals
Buy, Sell or Hold SUNPHARMA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

19 Apr
1522.80
(0.42%)
18 Apr
1516.40
(-1.38%)
16 Apr
1537.55
(-0.16%)
15 Apr
1540.05
(0.00%)
12 Apr
1540.00
(-3.99%)
10 Apr
1604.05
(0.09%)
09 Apr
1602.55
(0.18%)
08 Apr
1599.70
(-0.58%)
05 Apr
1609.00
(-0.64%)
04 Apr
1619.35
(-0.03%)
03 Apr
1619.85
(-0.15%)
02 Apr
1622.25
(-0.43%)
01 Apr
1629.25
(0.54%)
28 Mar
1620.55
(1.02%)
27 Mar
1604.15
(0.38%)
26 Mar
1598.10
(-0.67%)
22 Mar
1608.90
(2.79%)
21 Mar
1565.20
(1.02%)
20 Mar
1549.35
(0.06%)
19 Mar
1548.45
(-1.45%)
18 Mar
1571.25
(1.49%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Neutral
Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

1531.49

10 DMA
Bearish

1569.3

20 DMA
Bearish

1583.49

50 DMA
Bearish

1563.69

100 DMA
Bullish

1426.14

200 DMA
Bullish

1276.59


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 19, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1557.44 1542.87 1529.57 - -
R2 1542.87 1533.47 1527.31 1544 -
R1 1532.84 1527.67 1525.06 1535.1 1537.85
P 1518.27 1518.27 1518.27 1519.4 1520.78
S1 1508.24 1508.87 1520.55 1510.5 1513.25
S2 1493.67 1503.07 1518.29 1494.8 -
S3 1483.64 1493.67 1516.04 - -

Key Metrics

EPS

17.17

P/E

88.68

P/B

15.19

Dividend Yield

0.76%

Market Cap

3,65,371 Cr.

Face Value

1

Book Value

100.23

ROE

16.46%

EBITDA Growth

3,656.22 Cr.

Debt/Equity

0.08

Shareholding Pattern

  54.48% Total Promoter Holding
12.21% Mutual Fund Holdings
17.72% FIIs
8.97% Non Institution
5.06% Insurance Companies
0% Custodians
1.56% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Sun Pharmaceuticals Industries Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 11414.85 11303.95 12145.28 12486.02 12630.9
PROFIT 2166.01 2138.86 2284.5 2375.51 2583.5
EPS 9 8.3 8.4 9.9 10.5

Sun Pharmaceuticals Industries Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 4713.78 6068.52 4629.61 5202.75 5150.55
PROFIT 486.73 1916.97 526.31 888.63 788.32
EPS 2 -4.3 1.6 3.7 3

Profit & Loss (Figures in Rs. Crores)


Sun Pharmaceuticals Industries Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 16709.13 27825.18 29539.05 32473.22 27097.52 30524.51 33188.24 34995.53 39837.57 45081.01
PROFIT 4978.84 4581.78 5027.37 6932.28 2794.9 3661.85 3960.73 5728.26 6717.12 8604.93
EPS 18.47 25.79 23.51 32.66 10.7 13.38 17.45 9.52 14.2 35.68

Sun Pharmaceuticals Industries Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 3021.08 7921.92 8178.89 8366.9 9951.27 11825.95 13904.25 14487.76 16966.04 21379.36
PROFIT -59.51 -1560.14 -1349.86 -266.99 1114.26 1865.28 3017.87 906.04 -1337.5 3356.39
EPS 0 0 0 0 1.27 3.4 13.38 3.51 -0.42 7.05

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 239.93239.93239.93239.93239.93239.93239.93240.66207.12207.12
Reserves Total 55,755.4547,771.2946,222.8545,024.5241,169.1338,074.1836,399.7432,741.1525,382.5918,317.83
Equity Application Money00000000.6748.380
Total Shareholders Funds55,995.3848,011.2246,462.7845,264.4541,409.0638,314.1136,639.6732,982.4825,638.0918,524.95
Minority Interest3,320.093,054.893,017.053,860.243,313.543,884.163,790.864,085.252,851.191,921.18
Secured Loans 007.83257.49109.47114.35780.45284.23339.9974.94
Unsecured Loans 6,885.871,290.33,860.758,057.3910,404.8910,270.929,051.328,212.538,656.122,485.92
Total Debt6,885.871,290.33,868.588,314.8810,514.3610,385.279,831.778,496.768,996.112,560.86
Other Liabilities929.521,019.641,098.631,334.281,004.7462.711,341.822,105.512,718.682,610.76
Total Liabilities67,130.8653,376.0554,447.0458,773.8556,241.6653,046.2551,604.1247,67040,204.0725,617.75
APPLICATION OF FUNDS :
Gross Block 43,454.6338,707.3635,578.9935,115.9731,687.0426,948.8124,466.4222,180.4120,406.8310,485.12
Less: Accumulated Depreciation19,034.5116,042.214,026.0112,269.069,850.58,096.166,791.256,308.167,724.363,667.84
Net Block24,420.1222,665.1621,552.9822,846.9121,836.5418,852.6517,675.1715,872.2512,682.476,817.28
Capital Work in Progress4,973.161,286.81,566.831,220.341,411.152,465.162,801.382,175.452,038.61841.54
Investments 14,830.0912,848.599,612.4510,143.117,902.537,142.871,191.881,829.882,716.32,786.02
Inventories 10,513.058,925.138,997.027,874.997,885.986,880.696,832.816,422.545,667.993,123.01
Sundry Debtors 11,438.5110,484.599,061.49,421.248,884.27,815.287,202.616,775.665,106.132,200.42
Cash and Bank Balance5,770.295,033.356,445.516,487.557,275.69,929.3815,140.8413,181.6510,998.047,590.15
Loans and Advances 2,767.482,787.592,808.092,973.023,072.692,919.933,546.512,847.645,026.163,774.42
Total Current Assets30,489.3327,230.6627,312.0226,756.827,118.4727,545.2832,722.7729,227.4926,798.3216,688
Current Liabilities 7,917.957,076.428,413.455,382.085,288.66,008.655,328.34,536.854,166.361,516.82
Provisions 5,663.099,323.444,761.734,038.393,059.275,242.494,163.033,220.654,352.761,960.58
Total Current Liabilities & Provisions13,581.0416,399.8613,175.189,420.478,347.8711,251.149,491.337,757.58,519.123,477.4
Net Current Assets16,908.2910,830.814,136.8417,336.3318,770.616,294.1423,231.4421,469.9918,279.213,210.6
Deferred Tax Assets5,409.364,431.174,712.194,141.53,441.013,095.52,994.373,560.312,245.841,199.97
Deferred Tax Liability2,276.811,613.451,200.261,024.35990.42907.13816.34514.09494.2288.95
Net Deferred Tax3,132.552,817.723,511.933,117.152,450.592,188.372,178.033,046.221,751.64911.02
Other Assets2,866.652,926.984,066.014,110.013,870.256,103.064,526.223,276.212,735.851,051.29
Total Assets67,130.8653,376.0554,447.0458,773.8556,241.6653,046.2551,604.1247,67040,204.0725,617.75
Contingent Liabilities4,361.773,773.194,714.135,075.525,290.47,430.517,345.514,162.263,538.681,646.13
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 239.93239.93239.93239.93239.93239.93239.93240.66207.12207.12
Reserves Total 23,508.4324,348.0226,698.5424,156.2922,603.6822,082.6820,772.5421,649.3722,530.777,200.76
Equity Application Money00000000.6748.380
Total Shareholders Funds23,748.3624,587.9526,938.4724,396.2222,843.6122,322.6121,012.4721,890.722,786.277,407.88
Secured Loans 005.416.189.7310.8230.632,939.46281.638.81
Unsecured Loans 7,790.825,074.047,352.716,399.76,426.916,873.196,015.982,889.386,529.052,400.2
Total Debt7,790.825,074.047,358.126,405.886,436.646,884.016,046.615,828.846,810.682,409.01
Other Liabilities1,104.831,016.381,342.131,553.68176.19346.091,133.511,825.622,436.882,525.57
Total Liabilities32,644.0130,678.3735,638.7232,355.7829,456.4429,552.7128,192.5929,545.1632,033.8312,342.46
APPLICATION OF FUNDS :
Gross Block 17,744.6817,194.9815,812.298,244.717,461.346,572.664,988.084,103.75,995.071,973.53
Less : Accumulated Depreciation 9,033.017,482.26,143.53,015.972,482.921,928.09949.45529.082,809.8706.36
Net Block 8,711.679,712.789,668.795,228.744,978.424,644.574,038.633,574.623,185.271,267.17
Capital Work in Progress852.91828.641,090.38596.61642.54987.841,100.5767.731,090.59480.46
Investments 12,616.415,548.8715,537.217,361.7217,904.1118,355.2619,333.322,371.6925,876.167,015.73
Inventories 3,989.193,403.743,423.422,633.672,792.622,135.642,308.282,132.152,189.25918.38
Sundry Debtors 7,125.024,245.166,585.246,168.135,031.475,271.442,714.71,997.811,802.82980.15
Cash and Bank Balance421.28534.96360.98654.78340.77155.27170.28169.11416.46141.48
Loans and Advances 4,7081,326.852,329.442,089.472,756.961,968.11,154.92943.63947.822,799.43
Total Current Assets16,243.499,510.7112,699.0811,546.0510,921.829,530.456,348.185,242.75,356.354,839.44
Current Liabilities 7,533.987,524.566,891.414,956.615,713.964,586.353,829.253,541.693,345.031,141.07
Provisions 809.52,562.551,204.661,097.942,543.732,652.751,847.431,179.612,066.69688.03
Total Current Liabilities & Provisions8,343.4810,087.118,096.076,054.558,257.697,239.15,676.684,721.35,411.721,829.1
Net Current Assets7,900.01-576.44,603.015,491.52,664.132,291.35671.5521.4-55.373,010.34
Deferred Tax Assets1,982.841,389.471,969.41,704.221,427.47751.7751.7751.7389.3111.51
Deferred Tax Liability950.451,065.43631.95564.51675.7702.640389.31204.35
Net Deferred Tax1,032.39324.041,337.451,139.71751.7751.7749.06751.70-192.84
Other Assets1,530.634,840.443,401.892,537.52,515.542,521.992,299.61,558.021,937.18761.6
Total Assets32,644.0130,678.3735,638.7232,355.7829,456.4429,552.7128,192.5929,545.1632,033.8312,342.46
Contingent Liabilities1,087.41,031.723,083.043,439.723,639.135,708.855,636.82,584.822,016.32768.66

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...9,408.43
Depreciation2,529.43
Interest (Net)-212.54
Dividend Received132.4
Prov. and W/O (Net)214.69
P/L in Forex336.81
Total Adjustments (PBT and Ext...2,722.56
Operating Profit before Workin...12,130.99
Trade and 0ther Receivables-953.17
Inventories-1,202.2
Trade Payables1,182.37
Total Adjustments (OP before W...-5,661.82
Cash Generated from/(used in) ...6,469.17
Direct Taxes Paid-1,509.84
Total Adjustments(Cash Generat...-1,509.84
Cash Flow before Extraordinary...4,959.33
Net Cash from Operating Activi...4,959.33
Purchased of Fixed Assets-2,085.58
Sale of Fixed Assets21.01
Purchase of Investments-21,808.74
Sale of Investments20,896.84
Interest Received317.93
Investment in Group Cos.-155.49
Acquisition of Companies-4,685.82
Net Cash used in Investing Act...-7,219.92
Proceed from 0ther Long Term B...8,159.78
Of the Long Tem Borrowings-3,030.12
Of Financial Liabilities-134.62
Dividend Paid-2,519.73
Interest Paid-99.24
Net Cash used in Financing Act...2,376.07
Net Profit before Tax and Extr...1,741.05
Depreciation1,600.87
Interest (Net)251.98
Prov. and W/O (Net)2,954.11
P/L in Forex34
Total Adjustments (PBT and Ext...4,823.4
Operating Profit before Workin...6,564.45
Trade and 0ther Receivables-2,932.01
Inventories-585.45
Trade Payables406.36
Total Adjustments (OP before W...-5,625.38
Cash Generated from/(used in) ...939.07
Direct Taxes Paid-431.99
Total Adjustments(Cash Generat...-431.99
Cash Flow before Extraordinary...507.08
Net Cash from Operating Activi...507.08
Purchased of Fixed Assets-962.43
Sale of Fixed Assets8.3
Purchase of Investments-3,692.95
Sale of Investments3,695.25
Interest Received152.23
Cancellation of Investment in ...6
Acquisition of Companies-15.92
Net Cash used in Investing Act...-685.64
Proceed from 0ther Long Term B...8,216.92
Of the Long Tem Borrowings-5,492.96
Of Financial Liabilities-34.81
Dividend Paid-2,518.88
Interest Paid-0.96
Net Cash used in Financing Act...169.31

Company Details

Registered Office
AddressSun Pharma Advanced Res.Centre,
Tandalja
CityVadodara
StateGujarat
Pin Code390020
Tel. No.91-265-6615500
Fax. No.91-265-2354897
Emailsecretarial@sunpharma.com
Internethttp://www.sunpharma.com
Registrars
AddressSun Pharma Advanced Res.Centre
CityVadodara
StateGujarat
Pin Code390020
Tel. No.91-265-6615500
Fax. No.91-265-2354897
Emailsecretarial@sunpharma.com
Internethttp://www.sunpharma.com
Management
Name Designation
Dilip S ShanghviManaging Director
Sudhir V ValiaNon-Exec & Non-Independent Dir
Sailesh T DesaiWhole-time Director
Gautam DoshiNon-Exec. & Independent Dir.
Pawan GoenkaLead Independent Director
Rama BijapurkarIndependent Director
Anoop DeshpandeCompany Sec. & Compli. Officer
Sanjay K AsherIndependent Director
Rolf HoffmannIndependent Director
Aalok ShanghviWhole Time Director